cllsociety.org/2022/11/cll-...
As the world has seemingly moved on from COVID-19 and appears to be disinterested in hearing about anything related to rates of infection/community spread, hospitalizations, or how many succumb daily to COVID-19, we have noticed that the volume of media coverage and reliable up-to-date information is not making the daily headlines nearly as much as it used to.
However, we are still very much in a pandemic and those who are immunocompromised, including all of those with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) regardless of their treatment status, must remain diligent. Without up-to-date information, it is difficult to perform personalized COVID-19 risk assessments to determine what level of risk you are willing to accept for various social situations.
Therefore, CLL Society has decided to try something new throughout the upcoming winter months by providing a weekly updated COVID-19 Summary Report. The goal is to keep our community informed of the latest information available as we approach what Dr. Brian Koffman has referred to as a potential “winter of discontent” for those with CLL/SLL.
Here is our first weekly report (there is a lot of new information this week, so this particular update will be a bit lengthy).
As Dr. Koffman predicted, the coming months very well might be our community’s “winter of discontent,” due to the coronavirus doing its very best to continually outsmart us by mutating to the point that it evades previous natural immunity acquired by infection in previous months, evades protection provided by Evusheld, and has figured out how to make the only remaining monoclonal antibody treatment for COVID-19 infection (Bebtelovimab) ineffective.
While Evusheld was never meant to completely prevent COVID-19 infection, it has done an excellent job of preventing individuals from developing severe disease which can lead to hospitalization and death. Without that added layer of protection, CLL Society feels that it is time to prepare those in our community for what might come as a result. We want to stress that this is not a reason to panic or fear, but instead to pause and prepare for what might be coming in the next few weeks.
Please remember that at this time CLL Society still believes that receiving Evusheld and Bebtelovimab is worth obtaining for those who are eligible until the FDA and CDC determine that they are no longer effective!
It is also important to remember that even if Evusheld and Bebtelovimab are no longer tools in our COVID-19 arsenal, we are not being left with zero ways to protect ourselves against infection and severe disease. We still have the powerful oral antiviral Paxlovid and the outpatient option of receiving IV Remdesivir.
Also, we have the new bivalent vaccine,
pfizer.com/news/press-relea...
which is still free to the public at this time. However, uptake in the US has been very low with less than 20% of those eligible in the US having received it. If you have not yet obtained your bivalent booster, now is the time to talk with your healthcare provider to discuss receiving it. The bivalent booster may increase antibody levels and stimulate other important parts of the immune system including T cells that aren’t necessarily measurable with standard laboratory tests, even if you haven’t had a previously robust antibody response to other COVID-19 vaccine doses.
In the meantime, we encourage everyone to focus on reducing transmission once again until additional effective monoclonal antibody preventatives and treatments can be developed and authorized. Several are in the pipeline and being studied in clinical trials. CLL Society is communicating with several companies who are working hard to develop new options for us. Stay tuned for more news on this subject, hopefully coming in early 2023.
Thankfully, the virus cannot mutate around a well-fitted N95 mask, so please continue to mask up! Additionally, education and knowledge are both powerful tools, so please do your best to stay well-informed.
Also, make sure your COVID-19 Action Plan cllsociety.org/covid-19-hom... is kept up-to-date, have the suggested supplies listed within the plan on hand, practice good hand hygiene, have good ventilation whenever you are around others (especially those who are unmasked), wear an N95 or KN95 as much as possible when outside of your home, and practice social distancing as much as you possibly can.